首页 | 本学科首页   官方微博 | 高级检索  
   检索      

PEI-Et输送特异性shRNA对大鼠肝细胞AGT基因表达的影响
引用本文:王玉强,王飞,曹青,苏靖,盛净,陈书艳.PEI-Et输送特异性shRNA对大鼠肝细胞AGT基因表达的影响[J].现代生物医学进展,2014,14(7):1267-1270.
作者姓名:王玉强  王飞  曹青  苏靖  盛净  陈书艳
作者单位:[1]上海交通大学医学院附属新华医院老年科,上海200092 [2]上海交通大学药学院,上海200240 [3]上海交通大学医学院附属第九人民医院老年科,上海200011
基金项目:国家自然科学基金项目(81001416;81270205)
摘    要:目的:研究交联小分子量聚乙烯亚胺衍生物PEI-Et对大鼠肝细胞(BRL-3A)的细胞毒性、转染效率和携带高血压相关基因血管紧张素原(AGT)短发卡RNA(shRNA)沉默AGT表达的能力。方法:MTT法检测PEI-Et/shRNA复合物对BRL-3A细胞的毒性,流式细胞术检测PEI-Et/shRNA复合物对BRL-3A细胞的转染效率,RT-PCR和Western blot检测PEI-Et/shRNA对AGT的基因沉默效果。结果:在相同质量比(w/w)时PEI-Et/shRNA的细胞毒性小于PEI 25kDa/shRNA(P0.01),PEI-Et/shRNA在w/w为30时达到最高转染效率,高于PEI 25 kDa(P0.01),PEI-Et/shRNA能高效沉默BRL-3A细胞中AGT基因的表达。结论:PEI-Et在BRL-3A细胞中是一种低细胞毒性、高转染效率的非病毒基因载体(与商业化的PEI 25kDa比较),能携带AGT shRNA高效沉默BRL-3A细胞中AGT基因的表达,通过用PEI-Et/AGT shRNA来抑制AGT的表达将为高血压的基因治疗提供一种新的思路。

关 键 词:AGT  RNA干扰  BRL-3A  转染效率  细胞毒性

Effects of Delivery of Specific shRNA using PEI-Et on AGT Gene Expression in Rat Liver Cells
WANG Yu-qing,WANG Fei,CAO Qing,SU Jing,SHENG Jing,CHEN Shu-yan.Effects of Delivery of Specific shRNA using PEI-Et on AGT Gene Expression in Rat Liver Cells[J].Progress in Modern Biomedicine,2014,14(7):1267-1270.
Authors:WANG Yu-qing  WANG Fei  CAO Qing  SU Jing  SHENG Jing  CHEN Shu-yan
Institution:(I Department of Geriatrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China; 2 Shanghai Jiao Tong University School of Pharmacy, Shanghai, 200240, China; 3 Department of Geriatrics, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China)
Abstract:Objective: To synthesize cross-linked small-molecular-weight polyethylenimine derivative PEI-Et and investigate its cytotoxicity, transfection efficiency and ability to delivery hypertension related gene angiotensinogen (AGT) short hairpin RNA (shRNA) to silence AGT expression. Methods: MTT assay was used to measure the cytotoxicity of PEI-Et/shRNA complexes. Flow cytometry was performed to investigate transfection efficiency of PEI-Et/shRNA in BRL-3A cells. RT-PCR and Western blot were used to detect the AGT gene silencing effect of PEI-Et/shRNA. Results: PEI-Et/shRNA showed lower cytotoxicity than PEI 25kDa/shRNA at the same weight ratio (w/w). Transfection results indicated that PEI-Et/shRNA displayed the highest transfection efficiency at w/w 30, which was higher than PEI 25kDa/shRNA (P〈0.01). PEI-Et/shRNA could efficiently inhibit the expression of AGT in BRL-3A cells. Conclusion: PEI-Et was a non-viral vector with much lower cytotoxicity and enhanced transfection efficiency than PEI 25kDa in BRL-3A cells, and it could delivery AGT shRNA to efficiently silence AGT expression in BRL-3A cells. Therefore, PEI-Et/AGTshRNA would be a promising tool for delivering AGT shRNA to BRL-3A cells for hypertension therapy.
Keywords:AGT  RNA interference  BRL-3A  Transfection efficiency  Cytotoxicity
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号